13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

          The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

            Regulatory guidance specifies the need to establish cardiovascular safety of new diabetes therapies in patients with type 2 diabetes in order to rule out excess cardiovascular risk. The cardiovascular effects of semaglutide, a glucagon-like peptide 1 analogue with an extended half-life of approximately 1 week, in type 2 diabetes are unknown.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tirzepatide Once Weekly for the Treatment of Obesity

              Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in people with obesity are not known.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Obesity Surgery
                OBES SURG
                Springer Science and Business Media LLC
                0960-8923
                1708-0428
                April 2024
                March 02 2024
                April 2024
                : 34
                : 4
                : 1324-1332
                Article
                10.1007/s11695-024-07137-0
                38430320
                14e42581-c5a4-48cd-adcf-6fecd6ba711b
                © 2024

                https://www.springernature.com/gp/researchers/text-and-data-mining

                https://www.springernature.com/gp/researchers/text-and-data-mining

                History

                Comments

                Comment on this article

                scite_
                10
                0
                0
                0
                Smart Citations
                10
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content4,814

                Cited by4

                Most referenced authors917